Summit Therapeutics Ratios (2016-2025) | SMMT

Ratios Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Apr2018 Jul2018 Oct2018 Jan2019 Mar2019 Jul2019 Oct2019 Dec2019 Mar2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
EBT Margin 4,718.52%3,809.14%-959.55%-364.87%345.14%-96.08%-488.46%-175.22%71.50%-1,393.93%-1,173.27%-1,645.07%-6,255.65%-2,363.24%-7,700.00%2,478.89%729,144.44%
EBIT Margin 4,577.04%3,703.55%-917.53%-352.49%-332.23%-91.49%197.34%-170.08%64.53%-1,385.04%-1,164.36%-1,629.60%-6,205.65%-2,343.08%-7,700.00%2,378.89%729,044.44%
EBITDA Margin 4,029.63%3,252.28%-790.63%-285.82%276.39%-68.93%32.73%150.62%70.24%-1,204.15%-1,022.77%1,425.07%-5,682.26%1,946.25%-9,742.73%1,392.95%1,945.04%2,284.56%679,777.78%
Operating Margin 4,577.04%3,703.55%-917.53%-352.49%-332.23%-91.49%197.34%-170.08%64.53%-1,385.04%-1,164.36%-1,629.60%-6,205.65%-2,343.08%-7,700.00%2,378.89%729,044.44%
Net Margin 4,718.52%3,809.14%-959.55%-364.87%345.14%-96.08%-488.46%-175.22%71.50%-1,393.93%-1,173.27%-1,645.07%-6,255.65%-2,363.24%-7,700.00%2,478.89%729,144.44%
FCF Margin 4,717.04%3,809.64%-959.90%1,825.41%-460.19%4.59%180.52%-179.56%1,645.07%-29,615.81%-1,538.33%-3,879.55%965.65%1,065.93%1,236.96%540,966.67%
Efficiency
Assets Average 0.02B0.04B0.05B0.04B0.05B0.06B0.08B0.08B0.06B0.07B0.06B0.07B0.09B0.08B0.12B0.14B0.14B0.12B0.11B0.11B0.13B0.41B0.46B0.25B0.23B0.21B0.19B0.26B0.42B0.47B0.41B0.35B0.29B
Equity Average 0.06B0.07B0.09B0.11B0.09B0.07B0.06B0.09B0.13B0.13B0.13B0.11B0.09B0.06B0.12B0.32B0.41B0.37B0.30B0.23B
Invested Capital -0.00B-0.00B-0.00B0.01B-0.00B-0.00B-0.01B-0.02B0.01B0.00B-0.01B-0.01B0.09B-0.01B0.04B0.08B0.06B0.12B0.10B0.08B0.06B0.05B0.13B0.13B0.13B0.12B0.10B0.08B0.04B0.20B0.44B0.39B0.34B0.26B0.19B
Asset Utilization Ratio 0.050.110.240.240.220.871.000.850.040.020.010.01-0.01-0.02-0.02-0.02
Leverage & Solvency
Interest Coverage Ratio -31.85-34.7421.7528.33-25.63-19.8423.10-32.95-174.96155.82125.11101.85122.14-114.00-23.79-0.00B
Debt to Equity 0.000.390.493.900.750.841.292.26
Debt Ratio -0.15-0.23-0.07-0.11-0.10-0.09-0.08-0.19-0.14-0.13-0.180.00-0.140.220.260.740.390.420.490.57
Equity Ratio 0.820.650.780.460.820.800.730.550.540.860.190.520.500.450.380.250.570.870.890.900.800.73
Times Interest Earned -31.85-34.7421.7528.33-25.63-19.8423.10-32.95-174.96155.82125.11101.85122.14-114.00-23.79-0.00B
Valuation
Enterprise Value 0.09B0.06B0.10B0.09B0.10B0.14B0.09B0.15B0.01B-0.01B0.02B0.03B0.01B0.03B-0.01B0.02B0.21B0.32B0.38B0.62B0.49B0.19B0.24B0.10B-0.01B0.21B0.98B1.54B1.11B1.64B2.84B5.45B15.77B12.75B13.87B15.51B15.11B
Market Capitalization 0.12B0.09B0.14B0.13B0.14B0.17B0.13B0.19B0.03B0.02B0.06B0.06B0.04B0.05B0.05B0.08B0.23B0.39B0.49B0.73B0.49B0.26B0.24B0.10B0.12B0.86B1.22B1.75B1.30B1.83B2.91B5.48B15.87B13.16B14.23B15.80B15.35B
Return Ratios
Return on Sales -14.28%-3.78%-1.20%-1.67%-1.45%0.06%-0.04%0.12%0.16%-17.29%-33.25%-58.59%16.30%21.09%
Return on Capital Employed -0.89%-0.57%-0.46%-0.19%-0.14%0.28%0.24%0.07%-0.57%-0.30%-0.39%-0.15%-0.57%-0.49%-0.37%-0.42%
Return on Assets -0.68%-0.42%-0.29%-0.40%-0.32%0.05%-0.04%0.10%-0.68%-0.35%-0.34%-0.13%-0.29%-0.45%-0.33%-0.39%
Return on Equity -0.46%-0.42%-0.60%-1.06%-0.44%-0.44%